Related Experiment Videos
Long-term treatment with timolol ophthalmic solution in open-angle glaucoma
Summary
Timolol eye drops effectively stabilized glaucoma in a preselected patient group. Over three years, 77% of patients achieved satisfactory intraocular pressure control, demonstrating the drug
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Glaucoma and ocular hypertension require effective long-term management.
- Timolol is a common topical beta-blocker used for intraocular pressure reduction.
Purpose of the Study:
- To evaluate the efficacy of timolol eye drops in managing glaucoma and ocular hypertension.
- To assess long-term intraocular pressure control and glaucoma stabilization with timolol treatment.
Main Methods:
- A cohort of 96 patients (67 glaucoma, 29 ocular hypertension) was followed for an average of 30 months.
- Timolol eye drops (0.25% or 0.5%) were administered alone or in combination with other antiglaucoma medications.
- Patient outcomes regarding intraocular pressure control and disease progression were monitored.
Main Results:
- 76 patients (80%) achieved satisfactory intraocular pressure control.
- Glaucoma stabilization was observed in 77% of the preselected population over a 3-year period.
- Only 10 patients had unsatisfactory control, with 7 requiring trabeculectomy.
Conclusions:
- Timolol eye drops demonstrate significant efficacy in achieving long-term intraocular pressure control and stabilizing glaucoma.
- The study supports the use of timolol as a primary or adjunctive therapy for glaucoma management.
- A high percentage of patients, including those with advanced glaucoma, benefited from timolol treatment.